UNITAID

1

• UNITAID
• An innovative mechanism for scaling up access to
  medicines and diagnostics for HIV/AIDS,
  tuberculosis and malaria

2
Innovative Partnership for Public Good
2006 Founding countries Brazil, Chile,
France, Norway, UK
2009 Supported by 29 countries and the Gates
foundation
3
93 countries receiving UNITAID medicines and
diagnostics
Malaria 29 countries
TB 72 countries
4
Innovative Financing
Flexible 'Air Tax' Approach
One flight from Paris to New York carrying 300
passengers provides money to treat one multi-drug
resistant tuberculosis patient for one year
5
Comparative Advantage

• Market impact for medicines and diagnostics
  for HIV, TB and Malaria
• Availability
• Price
• Quality
• Delivery

Innovation can lead to leaps in progress
6
Innovative Approaches

• Predictable, Sustainable Financing
• Linking of diagnostics and treatments
• Procurement and Supply Management
• Medicines
• Equipment
• Consumables

Innovation is about new approaches
7
Innovation for TB

• Paediatric
• Child friendly formulations
• First-Line
• Uninterrupted supply
• MDR-TB Diagnostics
• New diagnostic tools
• MDR-TB
• Strategic Revolving Fund
• Enables access
• Strategic Rotating Stockpile
• Delivery lead time reduction

Improving the effectiveness of investments and
accelerating results
8
Innovative Challenges

• In 3 years

• In 2-3 years

• Today

• Ongoing actions/niches

• Additional ideas to explore

• 2nd line ARVs
• Pediatric ARVs RUTF
• PMTCT

• Viral load
• Some OI commodities (e.g., Isoniazid
  Cotrimoxazole, Rifabutin)
• Prevention commodities

• 3rd line ARVs
• Microbicides
• Point-of-care diagnostics
• Non-nutritional co-morbidities

• HIV/AIDS

• TB

• 1st line TB
• Pediatric TB
• MDR-TB

• Pediatric MDR-TB
• LED diagnostics (1st line)
• New MDR-TB regimens

• API market (transversal)
• XDR diagnostics drugs
• Point-of-care diagnostics

• Malaria

• ACTs
• Bed nets
• AMFm

• Rapid tests

• Residual spraying

• Other/
• transversal

• Prequalification

• Patent pool

• Pharmacovigilance
• Other diseases (where market impact is possible)

Voluntary Solidarity Contribution

9
(No Transcript)